<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article article-type="research-article" dtd-version="2.3" xml:lang="EN" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Pharmacol.</journal-id>
<journal-title>Frontiers in Pharmacology</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Pharmacol.</abbrev-journal-title>
<issn pub-type="epub">1663-9812</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="publisher-id">653232</article-id>
<article-id pub-id-type="doi">10.3389/fphar.2021.653232</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Pharmacology</subject>
<subj-group>
<subject>Original Research</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Cryptotanshinone Inhibits the Growth of HCT116 Colorectal Cancer Cells Through Endoplasmic Reticulum Stress-Mediated Autophagy</article-title>
<alt-title alt-title-type="left-running-head">Fu et al.</alt-title>
<alt-title alt-title-type="right-running-head">Cryptotanshinone Inhibits Colorectal Cancer Cells Growth</alt-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Fu</surname>
<given-names>Xiaojing</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="fn" rid="fn1">
<sup>&#x2020;</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/1031164/overview"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Zhao</surname>
<given-names>Wenwen</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<xref ref-type="fn" rid="fn1">
<sup>&#x2020;</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/600148/overview"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Li</surname>
<given-names>Kangkang</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Zhou</surname>
<given-names>Jingyi</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Chen</surname>
<given-names>Xuehong</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="corresp" rid="c001">&#x2a;</xref>
<uri xlink:href="https://loop.frontiersin.org/people/1119830/overview"/>
</contrib>
</contrib-group>
<aff id="aff1">
<label>
<sup>1</sup>
</label>School of Basic Medicine, Qingdao University, <addr-line>Qingdao</addr-line>, <country>China</country>
</aff>
<aff id="aff2">
<label>
<sup>2</sup>
</label>State Key Laboratory of Quality Research in Chinese Medicine, Institute of Chinese Medical Sciences, University of Macau, <addr-line>Macao</addr-line>, <country>China</country>
</aff>
<author-notes>
<fn fn-type="edited-by">
<p>
<bold>Edited by:</bold> <ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/688399/overview">Monica Montopoli</ext-link>, University of Padua, Italy</p>
</fn>
<fn fn-type="edited-by">
<p>
<bold>Reviewed by:</bold> <ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/959239/overview">Zahra Ahmadi</ext-link>, Azad Shoushtar University, Iran</p>
<p>
<ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/771321/overview">Chia-Che Chang</ext-link>, National Chung Hsing University, Taiwan</p>
</fn>
<corresp id="c001">&#x2a;Correspondence: Xuehong Chen, <email>chen-xuehong@163.com</email>
</corresp>
<fn fn-type="other">
<p>This article was submitted to Pharmacology of Anti-Cancer Drugs, a section of the journal Frontiers in Pharmacology</p>
</fn>
<fn fn-type="equal" id="fn1">
<label>
<sup>&#x2020;</sup>
</label>
<p>These authors have contributed equally to this&#x20;work</p>
</fn>
</author-notes>
<pub-date pub-type="epub">
<day>17</day>
<month>06</month>
<year>2021</year>
</pub-date>
<pub-date pub-type="collection">
<year>2021</year>
</pub-date>
<volume>12</volume>
<elocation-id>653232</elocation-id>
<history>
<date date-type="received">
<day>14</day>
<month>01</month>
<year>2021</year>
</date>
<date date-type="accepted">
<day>20</day>
<month>04</month>
<year>2021</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#xa9; 2021 Fu, Zhao, Li, Zhou and Chen.</copyright-statement>
<copyright-year>2021</copyright-year>
<copyright-holder>Fu, Zhao, Li, Zhou and Chen</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</p>
</license>
</permissions>
<abstract>
<p>Among cancers, colorectal cancer (CRC) has one of the highest annual incidence and death rates. Considering severe adverse reactions associated with classical chemotherapy medications, traditional Chinese medicines have become potential drug candidates. In the current study, the effects of cryptotanshinone (CPT), a major component of <italic>Salvia miltiorrhiza Bunge</italic> (<italic>Danshen</italic>) on CRC and underlying mechanism were explored. First of all, data from <italic>in vitro</italic> experiments and <italic>in vivo</italic> zebrafish models indicated that CPT selectively inhibited the growth and proliferation of HCT116 and SW620 cells while had little effect on SW480 cells. Secondly, both ER stress and autophagy were associated with CRC viability regulation. Interestingly, ER stress inhibitor and autophagy inhibitor merely alleviated cytotoxic effects on HCT116 cells in response to CPT stimulation, while have little effect on SW620 cells. The significance of apoptosis, autophagy and ER stress were verified by clinical data from CRC patients. In summary, the current study has revealed the anti-cancer effects of CPT in CRC by activating autophagy signaling mediated by ER stress. CPT is a promising drug candidate for CRC treatment.</p>
</abstract>
<kwd-group>
<kwd>cryptotanshinone</kwd>
<kwd>colorectal cancer</kwd>
<kwd>apoptosis</kwd>
<kwd>autophagy</kwd>
<kwd>endoplasmic reticulum stress</kwd>
</kwd-group>
</article-meta>
</front>
<body>
<sec id="s1">
<title>Introduction</title>
<p>Nowadays, changes in human dietary structure and increase in life pressure has resulted in increasing incidence of colorectal cancer (CRC), especially in relatively younger age groups (<xref ref-type="bibr" rid="B23">Miller et al., 2020</xref>; <xref ref-type="bibr" rid="B37">Siegel et al., 2020</xref>). Clinically, the treatment of CRC commonly involves a combination of three classic strategies of oncology: chemotherapy, surgery, and radiation therapy. However, the approach of using chemotherapeutic drugs for CRC has several limitations, especially side-effect of drugs after repeated administrations (<xref ref-type="bibr" rid="B34">Roessler et al., 2010</xref>). Although significant advances have been made in our understanding of the molecular basis of this tumor type, novel efficacious therapeutic avenues are urgently needed.</p>
<p>Endoplasmic reticulum (ER) stress is a recognized factor in tumor growth (<xref ref-type="bibr" rid="B36">Schleicher et al., 2010</xref>). ER stress signaling, also known as unfolded protein response (UPR), is a cellular adaptation mechanism that occurs when endoplasmic reticulum homeostasis is destroyed following nutrient deprivation, hypoxia, or oxidative stress (<xref ref-type="bibr" rid="B20">Lu et al., 2014</xref>; <xref ref-type="bibr" rid="B44">Wang &#x26; Kaufman, 2016</xref>; <xref ref-type="bibr" rid="B8">Fang et al., 2021</xref>). The UPR is induced by three ER-anchored transmembrane receptors&#x2014;inositol-requiring enzyme 1&#x3b1;(IRE1&#x3b1;), protein kinase RNA (PKR)-like ER kinase (PERK), and activating transcription factor-6 (ATF6), which detect misfolded proteins, expand ER protein folding capacity and decrease protein folding demand (<xref ref-type="bibr" rid="B41">Walter &#x26; Ron, 2011</xref>; <xref ref-type="bibr" rid="B31">Prasad &#x26; Greber, 2021</xref>). The UPR is an evolutionarily conserved stress response pathway tasked with reducing levels of unfolded/misfolded proteins and restoring ER homeostasis (<xref ref-type="bibr" rid="B36">Schleicher et al., 2010</xref>; <xref ref-type="bibr" rid="B46">Wang et al., 2021</xref>). If ER homeostasis cannot be restored, UPR drives the damaged or infected cells to apoptosis (<xref ref-type="bibr" rid="B9">Ferri &#x26; Kroemer, 2001</xref>; <xref ref-type="bibr" rid="B13">Huang et al., 2021</xref>; <xref ref-type="bibr" rid="B18">Li et al., 2021</xref>). When adaptive endoplasmic reticulum stress occurs, activation of UPR can induce protective autophagy and promote cell survival (<xref ref-type="bibr" rid="B35">Rouschop et al., 2010</xref>). However, it has been proven that triggering excessive stress on the persistent and severe endoplasmic reticulum can induce autophagy in tumor cells and ultimately lead to cell apoptosis (<xref ref-type="bibr" rid="B33">Rah et al., 2015</xref>; <xref ref-type="bibr" rid="B48">Xia et al., 2017</xref>; <xref ref-type="bibr" rid="B8">Fang et al., 2021</xref>; <xref ref-type="bibr" rid="B40">van Anken et al., 2021</xref>).</p>
<p>Autophagy is a process related to autophagy-related genes (ATG), which transports endogenous or exogenous cytoplasmic substances to lysosomes for degradation (<xref ref-type="bibr" rid="B24">Mokarram et al., 2019</xref>; <xref ref-type="bibr" rid="B54">Zhao et al., 2021</xref>). Thecytoplasmic form of LC3 (LC3-I) is conjured with phosphatidylethanolamine (PE) to form the LC3-phosphatidylethanolamine conjugation (LC3-II), which is known as a hallmark of autophagy (<xref ref-type="bibr" rid="B15">Kang et al., 2019</xref>; <xref ref-type="bibr" rid="B50">Xie et al., 2020</xref>). Beclin-1 plays an important role in autophagy initiation, which not only affects every link of autophagy, but also plays a key role in the regulation of the interaction between autophagy and apoptosis (<xref ref-type="bibr" rid="B16">Kang et al., 2011</xref>; <xref ref-type="bibr" rid="B28">Noguchi et al., 2020</xref>). It has been reported that the some chemotherapeutic drug-stimulated autophagy pathway can activate caspase-3, thereby inducing the apoptosis of tumor cells (<xref ref-type="bibr" rid="B25">Mowers et al., 2018</xref>). At same times, studies have confirmed that cell death in CRC can be achieved by inducing autophagy-dependent apoptosis pathways (<xref ref-type="bibr" rid="B30">Pedro et al., 2015</xref>; <xref ref-type="bibr" rid="B11">Grasso et al., 2016</xref>; <xref ref-type="bibr" rid="B27">Nagappan et al., 2017</xref>; <xref ref-type="bibr" rid="B48">Xia et al., 2017</xref>; <xref ref-type="bibr" rid="B22">Maranh&#xe3;o et al., 2020</xref>).</p>
<p>Herbs have recently aroused more and more interests in the discovery of anticancer therapies because they have long been used as alternative therapies for various diseases, including cancer, coronary heart disease, and diabetes, with relatively fewer side effects (<xref ref-type="bibr" rid="B56">Zhao et al., 2019</xref>; <xref ref-type="bibr" rid="B12">He et al., 2020</xref>; <xref ref-type="bibr" rid="B39">Sun et al., 2020</xref>; <xref ref-type="bibr" rid="B55">Zhao et al., 2020</xref>; <xref ref-type="bibr" rid="B57">Zheng et al., 2020</xref>). Multiple studies have reported that some active ingredients of <italic>Salvia miltiorrhiza Bung</italic>e (<italic>Danshen</italic>) have anti-tumor activities, including hepatoma, and prostatic cancer (<xref ref-type="bibr" rid="B51">Xu et al., 2012</xref>; <xref ref-type="bibr" rid="B21">Luo et al., 2020</xref>; <xref ref-type="bibr" rid="B42">Wang et al., 2020</xref>). Cryptotanshinone (CPT) is one important active ingredient from <italic>Danshen</italic> and is usually used to treat atherosclerosis, alzheimer&#x2019;s disease, hyperlipidemia, liver fibrosis, chronic renal failure, and gynecological diseases in Asian countries, with few reported serious side effects (<xref ref-type="bibr" rid="B51">Xu et al., 2012</xref>; <xref ref-type="bibr" rid="B3">Cai et al., 2016</xref>; <xref ref-type="bibr" rid="B7">Ding et al., 2016</xref>; <xref ref-type="bibr" rid="B19">Liu et al., 2020</xref>). Currently, many researchers are investigating CPT and have reported that CPT exhibits direct cytotoxic effects on multiple types of cancer cells. while exact mechanism is yet to be elucidated. In the current study, effects of CPT on CRC cells and underlying mechanism were explored.</p>
</sec>
<sec sec-type="materials|methods" id="s2">
<title>Materials and Methods</title>
<sec id="s2-1">
<title>Materials</title>
<p>RPMI1640 (Jinuo, Jiangsu, China); Fetal bovine serum (BiologicalIndustrie, Israel); ER Stress Antibody Sampler Kit (CST, United States); ATF-4; Caspase-3 (CST, United States); Cleaved caspase-3(CST, United States); LC3B (Zenbio, Chengdu, China); Anti-mouse (CST, United States); Anti-rabbit (CST, United States); JC-1 (Beyotime, Shanghai, China); LDH Cytotoxicity Assay Kit (Beyotime, Shanghai, China); Autophagy Antibody Sampler Kit (CST,United States); FITC Annexin &#x2164; Apoptosis Detection Kit (BD, US); Sodium 4-phenylbutyrate (4-PBA) (Bidepharm, Shanghai, China); Spautin-1; 4% Paraformaldehyde (4% PFA) (Solarbio, Beijing, China); 0.5% Crystal violet (Solarbio, Beijing, China); spautin-1; Immunohistochemistry (IHC) detection system kit (Rabbit) (Bioss, Beijing, China); Cryptotanshinone (Herbest, Shanxi, China); 0.003% tricaine (Sigma, United States); DiI (Invitrogen, Carlsbad, CA, United States); Nanoliter Injector (Drummond Scientific Company, Broomall, PA); Cisplatin Injection (Xinnuo, Jiangsu, China); dimethyl sulfoxide (DMSO) (Solarbio, Beijing, China); RIPA buffer (Solarbio, Beijing, China); Acridine orange detection kit (Leagene, Beijing, China).</p>
</sec>
<sec id="s2-2">
<title>Cell Culture</title>
<p>CRC cells (HCT116, SW480, and Sw620) were cultured in RPMI1640 supplemented with 10% FBS and 1% penicillin/streptomycin at 37&#xb0;C in a humidified atmosphere with 5% CO<sub>2</sub>.</p>
</sec>
<sec id="s2-3">
<title>Clinical Samples</title>
<p>The procedures in the current study has been formally approved by the ethics committee of Qingdao University (Qingdao, China) and written consent forms were approved by all patients. In this study, tumor tissues were collected from 56 patients with colorectal cancer who underwent surgery between June 2019 and February 2020. Diagnosis and staging were carried out by 2 independent senior oncologists blinded to the data. Colorectal cancer tissues and adjacent non-cancer tissues were collected and stored at &#x2212;80&#xb0;C until further uses.</p>
</sec>
<sec id="s2-4">
<title>MTT Assay</title>
<p>Cells at a density of 5 &#xd7; 10<sup>3</sup> per well were seeded in 96-well plates, treated for 24 or 48&#xa0;h, and then the viability of treated cells was determined with the MTT assay according to the supplier&#x2019;s instructions.</p>
</sec>
<sec id="s2-5">
<title>Colony-Forming Assay</title>
<p>The cells were seeded in a 6-well plate at a density of 600 cells/well for 24&#xa0;h, and then stimulated with drugs for 8&#xa0;h. After the treatment, incubation was continued for 14&#xa0;days in a complete culture medium at 37&#xb0;C and 5% humidified CO<sub>2</sub>. At the end of incubation, the cells were washed twice with PBS, fixed with methanol for 15&#xa0;min, and stained with 0.5% crystal violet for 15&#xa0;min at room temperature. A colony is defined as accumulation of at least 50 cells. The visible colonies were counted, and the colony formation rate was calculated with the following equation:<disp-formula id="equ1">
<mml:math id="mequ1">
<mml:mrow>
<mml:mtext>Colony</mml:mtext>
<mml:mtext>&#x2009;</mml:mtext>
<mml:mtext>formation</mml:mtext>
<mml:mtext>&#x2009;</mml:mtext>
<mml:mtext>rate</mml:mtext>
<mml:mo>&#x3d;</mml:mo>
<mml:mrow>
<mml:mo>(</mml:mo>
<mml:mrow>
<mml:mrow>
<mml:mrow>
<mml:mtext>number</mml:mtext>
<mml:mtext>&#x2009;</mml:mtext>
<mml:mtext>of</mml:mtext>
<mml:mtext>&#x2009;</mml:mtext>
<mml:mtext>colonies</mml:mtext>
</mml:mrow>
<mml:mo>/</mml:mo>
<mml:mrow>
<mml:mtext>number</mml:mtext>
<mml:mtext>&#x2009;</mml:mtext>
<mml:mtext>of</mml:mtext>
<mml:mtext>&#x2009;</mml:mtext>
<mml:mtext>inoculated</mml:mtext>
<mml:mtext>&#x2009;</mml:mtext>
<mml:mtext>cells</mml:mtext>
</mml:mrow>
</mml:mrow>
</mml:mrow>
<mml:mo>)</mml:mo>
</mml:mrow>
<mml:mo>&#xd7;</mml:mo>
<mml:mn>100</mml:mn>
<mml:mo>%</mml:mo>
<mml:mtext>.</mml:mtext>
</mml:mrow>
</mml:math>
</disp-formula>
</p>
</sec>
<sec id="s2-6">
<title>Lactate Dehydrogenase Cytotoxicity Assay</title>
<p>LDH assay was used to detect cytotoxicity following different treatments, using a LDH assay kit. Studies were performed following the instructions provided by the manufacturer.</p>
</sec>
<sec id="s2-7">
<title>Flow Cytometry Assay</title>
<p>After drug treatment, the cells were washed with PBS, and digested with trypsin. After the cells were collected, they were washed with PBS for 2 times and centrifuged. The cells were resuspended with Annexin &#x2164;-FITC binding buffer; Add Annexin &#x2164;-FITC to the cell suspension and incubate for 15&#xa0;min in the dark The PI was added, and the cells were filtered and detected by flow cytometry. Data were analyzed with the CytExpert software (Beckman Coulte, United States).</p>
</sec>
<sec id="s2-8">
<title>Western Blotting Analysis</title>
<p>Wash cells with precooled PBS. RIPA cell lysate is used to lyse cells. After the protein was heated and denaturated, 15&#x2013;30&#xa0;&#x3bc;g of protein was taken from each sample for protein electrophoresis. After membrane transfer, the PVDF membrane was sealed with 5% skimmed milk at room temperature for 60&#xa0;min. Then, they were incubated overnight in a buffer containing the antibodies at 4&#xb0;C. Wash 3 times with PBST (PBS with 0.1% Tween-20), and the corresponding HRP-linked Antibody was selected and incubated at room temperature for 1&#xa0;h. After washing again with PBS for 3 times, drop ECL chemiluminescence solution. Photographs were taken in a chemiluminescence imager. Densitometry analysis was performed with Image J software (NIH, United States).</p>
</sec>
<sec id="s2-9">
<title>JC-1 Assay</title>
<p>Cells at 5 &#xd7; 10<sup>3</sup> per well were seeded in 96-well plates, treated with different concentrations of CPT for 48&#xa0;h. The cells were washed twice with warm PBS and incubated with JC-1 (2&#xa0;&#xb5;M final concentration) for 30&#xa0;min in the dark. After two more washes with PBS, images were captured with an fluorescence microscope. Densitometry analysis was performed with Image J software (NIH, United States).</p>
</sec>
<sec id="s2-10">
<title>Acridine Orange Staining</title>
<p>Cells were cultured in a 24-well plate at a density of 5&#x2013;10 &#xd7; 104 per well overnight; treatments were then performed as described in triplicate for 48&#xa0;h. Then the supernatant was aspired, cells were rinsed with PBS for three times, and then 0.5&#xa0;ml of 0.1&#xa0;mg/ml acridine orange working solution was added to each well. Cells were incubated in a 5% CO<sub>2</sub>, 37&#xb0;C constant temperature incubator for 15&#xa0;min (avoid light), and then the supernatant was aspired, pictures were taken with an inverted fluorescence microscope after three washes with PBS.</p>
</sec>
<sec id="s2-11">
<title>Immunohistochemistry Analysis</title>
<p>Continuous sections were acquired from formalin fixed, paraffin-embedded tumor tissues, dewaxed in xylene, rehydrated in gradient ethanol, immersed in deionized water, and heated in 0.01&#xa0;M sodium citrate antigen-repair buffer in microwave oven for 15&#xa0;min. The Sections were then treated with 3% hydrogen peroxide in methanol (endogenous peroxidase blocker) for 30&#xa0;min, and then blocked with 5% bovine serum albumin (BSA) to block non-specific binding for 15&#xa0;min. Place in PBS buffer for 10&#xa0;min and repeat 3 times. Then the sections were incubated with primary antibody (BIP [1:200], LC3B [1:100], cleaved caspase-3 [1:250]) overnight at 4&#xb0;C. After incubation with a secondary antibody, 3, 3&#x2019;-diaminobenzidine tetrachloride was used to visualize the stainings. After counterstaining with hematoxylin, sections were dehydrated in ethanol, cleared in xylene, and sealed with resin. The sections were photographed under a microscope and analyzed with Image J software (NIH, United States).</p>
</sec>
<sec id="s2-12">
<title>
<italic>In Vivo</italic> Tumor Growth Model</title>
<p>At the night before injection, female and male zebrafishes were matched at a ratio of 1:2 and placed in the mating aquarium; 2&#xa0;h after fertilization, the zebrafishes were treated with PTU (1-phenyl-2-thiourea, 0.2&#xa0;mM) for lucidification. HCT116 and SW620 cells were labeled with DiI. 48 2 hpf zebrafish were anesthetized with 0.003% tricaine. Then microinjections of the cell suspensions into the yolk sac was performed on 48 2 hpf zebrafish embryos with Nanoject II automatic booster syringe. Carbon dioxide injection was used to ensure the 5&#xa0;nL injection volume. After receiving corresponding treatments, the animals were kept for 3 days. At 0 and 3 days after injection, animals were anesthetized with 70% ethanol, and then subjected to fluorescence microscopy. All experiments were approved by the Animal Research Ethics Committee of the University of Qingdao.</p>
</sec>
<sec id="s2-13">
<title>Statistical Analysis</title>
<p>Data were expressed as the means &#xb1; SD from three independent experiments. Statistics were performed with Prism 5.0 statistical analysis software. After normality tests, the mean differences of groups were assessed with one way analysis of variance (one-way ANOVA), followed by post hoc Student Newman-Keuls test. All statistical tests were two-sided, and <italic>p</italic> &#x3c; 0.05 was considered to be significant. Calculated <italic>p</italic>-values of <italic>p</italic> &#x3c; 0.05, <italic>p</italic> &#x3c; 0.01, and <italic>p</italic> &#x3c; 0.001 were as indicated.</p>
</sec>
</sec>
<sec sec-type="results" id="s3">
<title>Results</title>
<sec id="s3-1">
<title>Cryptotanshinone Treatment Selectively Inhibited CRC Cells Proliferation</title>
<p>The incidence of colorectal cancer is among the top three worldwide (<xref ref-type="bibr" rid="B38">Siegel et al., 2020a</xref>; <xref ref-type="bibr" rid="B37">Siegel et al., 2020</xref>). CPT exhibited potent cytotoxicity on a series of CRC cells while underlying mechanisms are unclear. In the current study, three main types of CRC cells (HCT116, SW620, and SW480) were treated with CPT. As shown in <xref ref-type="fig" rid="F1">Figures 1A&#x2013;C</xref>, CPT treatment significantly inhibited SW620 and HCT116 cells proliferation and growth in a dose and time- dependent manner (optimum stimulation time:48&#xa0;h; stimulation dose:10&#xa0;&#x3bc;M), while no remarkable cytotoxicity were observed on SW480 cells. Additionally, the results of LDH assay and colony-forming assay in both HCT116 and SW620 cells further indicated that CPT treatment selectively induced cytotoxicity in HCT116 and SW620 cells (<xref ref-type="fig" rid="F1">Figures 1D&#x2013;F</xref>).</p>
<fig id="F1" position="float">
<label>FIGURE 1</label>
<caption>
<p>The role of CPT against colorectal cancer. MTT assay <bold>(A)</bold> was used to measure the activity of SW480, HCT116, and SW620 cells treated with concentrations of CPT for 48&#xa0;h. SW620 and HCT116 were cultured in different concentrations of CPT or cisplatin (Cis) for 24 or 48&#xa0;h, respectively, and cell proliferation rates were analyzed by MTT assay <bold>(B,C)</bold>. Colony formation assay of SW620 and HCT116 cells treated with the indicated concentrations of CPT. Representative images <bold>(Left)</bold> and quantification of colonies <bold>(Right)</bold> were shown <bold>(D)</bold>. HCT116 cells and SW620 cells were treated with different concentrations of CPT for 48&#xa0;h, and the release amount of lactate dehydrogenase was analyzed by LDH assay, and the cytotoxicity was calculated <bold>(E,F)</bold>. CPT, cryptotanshinone; LDH, lactate dehydrogenase; Cis, cisplatin.</p>
</caption>
<graphic xlink:href="fphar-12-653232-g001.tif"/>
</fig>
</sec>
<sec id="s3-2">
<title>Cryptotanshinone Treatment Inhibited HCT116 and SW620 Tumor Growth in Zebrafish Models</title>
<p>To further verify the data from <italic>in vitro</italic> experiments, xenograft zebrafish model was established to simulate the internal environment to evaluate the anti-tumor effects of CPT. As shown in <xref ref-type="fig" rid="F2">Figure 2</xref>, the growth of the tumor formed with either HCT116 (<xref ref-type="fig" rid="F2">Figure 2A</xref>) or SW620 (<xref ref-type="fig" rid="F2">Figure 2B</xref>) was significantly inhibited after 3&#xa0;days of CPT treatment at a concentration of 50, 100&#xa0;nM, which was consistent with the data from <italic>in vitro</italic> experiments.</p>
<fig id="F2" position="float">
<label>FIGURE 2</label>
<caption>
<p>The inhibitory effects of different concentrations of CPT on tumor growth of HCT116 and SW620 zebrafish models were determined. The inhibitory effects of different concentrations of CPT on tumor growth of HCT116 and SW620 zebrafish were determined. The tumor was indicated by red fluorescence <bold>(A)</bold>, calculated as a percentage of the control value (<italic>n</italic> &#x3d; 8) <bold>(B)</bold>. CPT, cryptotanshinone.</p>
</caption>
<graphic xlink:href="fphar-12-653232-g002.tif"/>
</fig>
</sec>
<sec id="s3-3">
<title>Cryptotanshinone Induced HCT116 and SW620 Cells Apoptosis</title>
<p>Exact mechanisms of CPT-induced CRC cell death remain unknown, and were further explored in the current study. To examine whether apoptosis is associated with the anti-cancer effect of CPT, we used JC-1 staining to detect changes in mitochondria, Western blotting analysis to detect apoptosis-related proteins, and flow cytometry to evaluate the apoptotic ratio using flow cytometry. As shown in <xref ref-type="fig" rid="F3">Figures 3A&#x2013;G</xref>, CPT treatment significantly induced apoptosis in CRC cells. Increased cleaved caspase-3 expression levels were observed in CPT-treated CRC cells and maximized at 48&#xa0;h in HCT116 cells and at 12&#xa0;h in SW620 cells (<xref ref-type="fig" rid="F3">Figures 3A,B</xref>). Besides, based on JC-1 assay, much more green fluorescence was observed in CPT-treated cells and green/red ratio were remarkably increased in cells treated with CPT, indicating severe mitochondrial destruction (<xref ref-type="fig" rid="F3">Figures 3C,D</xref>). IHC was used to detect clinical samples, and the results showed that the expression of cleaved caspase3 in colorectal cancer tissues was significantly lower than that in non-cancerous tissues (<xref ref-type="fig" rid="F3">Figure 3F</xref>). Collectively, CPT inhibited CRC growth by inducing apoptosis accompanied with mitochondrial dysfunction.</p>
<fig id="F3" position="float">
<label>FIGURE 3</label>
<caption>
<p>CPT can induce apoptosis of CRC cells. Caspase 3 and cleaved caspase3 in the lysates of HCT116 and SW620 cells treated with CPT (10&#xa0;&#x3bc;M) for different time were detected by western blot assay and quantified by Image J <bold>(A,B)</bold>. The JC-1 assay was used to detect HCT116 cells and SW620 cells treated with different concentrations of CPT for 48&#xa0;h. The change of red or green color was observed under fluorescence microscope (200 &#xd7;) <bold>(C)</bold> and green/red was calculated <bold>(D)</bold> (<italic>n</italic> &#x3d; 3). Apoptosis of HCT116 cells and SW620 cells treated as in (C) was determined by Annexin &#x2164;-FITC/PI staining <bold>(E)</bold>. The immunohistochemical analysis of the clinical samples were performed, and the expression of cleaved caspase3 was detected in the tumor tissue and the corresponding para-cancer tissue, and the quantification analysis was performed with Image J <bold>(F)</bold>. CPT, cryptotanshinone; CRC, colorectal cancer.</p>
</caption>
<graphic xlink:href="fphar-12-653232-g003.tif"/>
</fig>
</sec>
<sec id="s3-4">
<title>Cryptotanshinone Promoted HCT116 Cells Apoptosis via Autophagy, Which Was Suppressed in CRC Tissues From Patients</title>
<p>Growing evidence has indicated that autophagy is closely linked with apoptosis induction (<xref ref-type="bibr" rid="B14">Jhou et al., 2020</xref>). Meanwhile CPT is considered as an important inducer of autophagy (<xref ref-type="bibr" rid="B52">Xu et al., 2017</xref>). In the current study, expression levels of autophagy-related proteins were increased with CPT treatment in a time- and concentration-dependent manner in HCT116 cells but not in SW620 cells, suggesting that CPT induced autophagy to regulate HCT116 cells viability (<xref ref-type="fig" rid="F4">Figures 4A&#x2013;C</xref>). To further explore the role of autophagy in the biological process of HCT116 cells, impacts of autophagy inhibitor treatment on CPT-induced cytotoxicity was tested on HCT116 cells (<xref ref-type="fig" rid="F5">Figures 5A,B</xref>). As shown in <xref ref-type="fig" rid="F5">Figure 5C&#x2013;E</xref>, autophagy inhibitor Spautin-1 effectively ameliorated CPT-induced cytotoxicity in HCT116 cells. In addition, our study also confirmed that spautin-1 can effectively inhibit CPT induced apoptosis (<xref ref-type="fig" rid="F5">Figures 5F,G</xref>). Therefore, the induction of HCT116 cell death by CPT is likely mediated via autophagy mediated apoptosis. In the clinical samples, the results from IHC staining showed that the expression levels of LC3B were remarkably higher while those of cleaved caspase 3 were significantly lower in CRC tissues relative to matched non-cancerous tissues (<xref ref-type="fig" rid="F3">Figures 3F</xref>, <xref ref-type="fig" rid="F4">4D</xref>). Above data showed that autophagy was the potential target for CPT in CRC treatment.</p>
<fig id="F4" position="float">
<label>FIGURE 4</label>
<caption>
<p>In CRC cells, autophagy mediates the anti-tumor effect of CPT. LC3B, Beclin-1, and ATG12&#x2013;5 of HCT116 cells <bold>(A)</bold> and SW620 cells <bold>(B)</bold> treated with different concentrations of CPT or Cis for 48&#xa0;h was detected by immunoblotting and quantitatively analyzed by ImageJ. LC3B, Beclin-1, and ATG12&#x2013;5 in HCT116 cells treated with CPT at a concentration of 10&#xa0;&#x3bc;M for different times was detected by western blot and quantitatively analyzed by Image J <bold>(C)</bold>. The immunohistochemical analysis of the clinical samples were performed, and the expression of LC3 was detected in the tumor tissue and the corresponding para-cancer tissue, and the quantification analysis was performed with Image J <bold>(D)</bold>. CPT, cryptotanshinone; CRC, colorectal cancer.</p>
</caption>
<graphic xlink:href="fphar-12-653232-g004.tif"/>
</fig>
<fig id="F5" position="float">
<label>FIGURE 5</label>
<caption>
<p>CPT can induce autophagy - mediated apoptosis in CRC cells. HCT116 cells were treated with or without CPT (10&#xa0;&#x3bc;M) for 48&#xa0;h in culture medium in the presence or absence of spautin-1 (20&#xa0;&#x3bc;M). The expression of autophagy-related proteins (ATG12&#x2013;5, Beclin-1, LC3B) in cell lysate was measured by western blot <bold>(A)</bold>. Fluorescence microscopy (200 &#xd7;) following AO staining detected the number of autophagosomes in HCT116 cells treated as in (A), and quantitative analysis was performed by ImageJ <bold>(B)</bold>. In the presence or absence of spautin-1 (20&#xa0;&#x3bc;M), the colony formation assay of HCT116 cells treated with or without 10&#xa0;&#x3bc;M CPT was performed, and the left image was representative and the right image was quantitative <bold>(C)</bold>. MTT assay <bold>(D)</bold>, and LDH release <bold>(E)</bold> assay were used to determine HCT116 cells treated as in <bold>(C)</bold>. Caspase-3 and PARP in HCT116 cells treated as in <bold>(A)</bold> were analyzed by western blotting assay and quantitatively analyzed by ImageJ <bold>(F)</bold>. Apoptosis of HCT116 cells treated as in <bold>(C)</bold> was quantified by flow cytometry <bold>(G)</bold>. CPT, cryptotanshinone; LDH, lactate dehydrogenase; CRC, colorectal cancer; AO, acridine orang.</p>
</caption>
<graphic xlink:href="fphar-12-653232-g005.tif"/>
</fig>
</sec>
<sec id="s3-5">
<title>Cryptotanshinone Monitored HCT116 Cells Apoptosis Mediated by Endoplasmic Reticulum Stress Which Was Lowly Expressed in CRC Tissues From Patients</title>
<p>It is generally accepted that the generation of endoplasmic reticulum stress plays an important role in apoptosis by changing the internal environment of cells (<xref ref-type="bibr" rid="B1">Alper et al., 2020</xref>) (<xref ref-type="bibr" rid="B47">Wu et al., 2020</xref>). Recent studies reported that CPT is a crucial ER stress promoter in some colorectal cancers (<xref ref-type="bibr" rid="B43">Wang L. et al., 2020</xref>). Therefore, the roles of endoplasmic reticulum stress in growth of HCT116 and SW620 were explored in the current study. First of all, overexpression of ER stress protein was observed in both HCT116 and SW620 cells exposed to CPT (<xref ref-type="fig" rid="F6">Figures 6A,B</xref>), which was further confirmed by the IHC results from human colon cancer tissues (<xref ref-type="fig" rid="F6">Figure 6I</xref>). Next, based on results of MTT assay, LDH assay and plate cloning assay, ER stress inhibitor 4-PBA significantly alleviated CPT-induced damages on HCT116 cells, while no remarkable effects were observed on SW620 cells. Such results further revealed the specific selectivity of CPT on CRC cells and this regulation is likely mediated via ER stress (<xref ref-type="fig" rid="F6">Figures 6C&#x2013;G</xref>). Furthermore, apoptosis induced by CPT could be abolished by 4-PBA treatment, which indicated that CPT induced ER stress could induce apoptosis on HCT116 cells (<xref ref-type="fig" rid="F6">Figure 6H</xref>).</p>
<fig id="F6" position="float">
<label>FIGURE 6</label>
<caption>
<p>In HCT116 cell, ER stress mediates the anti-tumor effect of CPT. Western blot was used to determine BIP in HCT116 cells and SW620 cell lysates treated with CPT (10&#xa0;&#x3bc;M) for different times <bold>(A)</bold>. PERK and p-PERK was detected in HCT116 cells treated as in (A) using western blotting analysis <bold>(B)</bold>. In the presence or absence of 4-PBA (1, 2, and 2.5 mM), HCT116 cells, and SW620 cells treated or untreated with CPT (10&#xa0;&#x3bc;M) were cultured for 48&#xa0;h and tested by MTT assay <bold>(C, E)</bold> and LDH assay <bold>(D, F)</bold>. In the presence or absence of 4-PBA (2 mM), the colony formation assay of HCT116 cells treated with or without CPT (10&#xa0;&#x3bc;M) was performed and quantified with Image J <bold>(G)</bold>. Apoptosis of HCT116 cells treated as in <bold>(G)</bold> was detected by flow cytometry <bold>(H)</bold>. The immunohistochemical analysis of the clinical samples were performed, and the expression of BIP was detected in the tumor tissue and the corresponding para-cancer tissue, and the quantification analysis was performed with Image J <bold>(I)</bold>. CPT, cryptotanshinone; ER stress, endoplasmic reticulum stress; LDH, lactate dehydrogenase.</p>
</caption>
<graphic xlink:href="fphar-12-653232-g006.tif"/>
</fig>
</sec>
<sec id="s3-6">
<title>Endoplasmic Reticulum Stress Lied Upstream of Autophagy Leading to HCT116 Cells Death in Response to CPT Treatment</title>
<p>In the current study, both ER stress and autophagy were shown to be involved in the apoptotic process of HCT116 cells in response to CPT treatment while the association between them still needs to be explored. As shown in <xref ref-type="fig" rid="F7">Figure 7A,B,D</xref>, ER stress inhibitor 4-PBA effectively inhibited the expression of autophagy-related proteins such as Beclin-1 and LC3B in CPT-treated HCT116 cells. However, autophagy inhibitor spautin-1 had little effects on the expression of BIP. We speculated that in HCT116 cells, ER stress is located upstream of autophagy pathway in damaged HCT116 cells (<xref ref-type="fig" rid="F7">Figure 7C</xref>). Our results showed that autophagy induced by CPT could be inhibited by 4-PBA, which was subsequently verified by Acridine orange staining.</p>
<fig id="F7" position="float">
<label>FIGURE 7</label>
<caption>
<p>CPT induced ER stress mediated autophagy in HCT116 cells. Expression levels of PERK and P-PERK in HCT116 cells treated with or without 4-PBA (2&#xa0;mM) in the presence or absence of CPT (10&#xa0;&#x3bc;M) <bold>(A)</bold>. HCT116 cells treated with or without Spautin-1 (20&#xa0;&#x3bc;M) for 48&#xa0;h were treated with or without CPT (10&#xa0;&#x3bc;M). The expression of BIP in the lysate was determined by western blot and quantified by Image J <bold>(B)</bold>. To test for Beclin-1 and LC3 expression in 10&#xa0;&#x3bc;M CPT processed or untreated HCT116 cells, with or without 4-PBA (2&#xa0;mM) <bold>(C)</bold>. Under fluorescence microscope (200 &#xd7;), the number of autophagosomes in HCT116 cells was stained by AO staining and quantified by ImageJ software <bold>(D)</bold>. CPT, cryptotanshinone; ER stress, endoplasmic reticulum stress; AO, acridine orang.</p>
</caption>
<graphic xlink:href="fphar-12-653232-g007.tif"/>
</fig>
</sec>
</sec>
<sec sec-type="discussion" id="s4">
<title>Discussion</title>
<p>CPT is a major component derived from <italic>Salvia miltiorrhiza</italic> (<xref ref-type="bibr" rid="B52">Xu et al., 2017</xref>; <xref ref-type="bibr" rid="B4">Chen et al., 2020</xref>; <xref ref-type="bibr" rid="B19">Liu et al., 2020</xref>). Nowadays, multiple studies have confirmed that CPT has inhibitory effect on a variety of cancer cells, such as liver cancer, non-small cell lung cancer, breast cancer, and ovarian cancer (<xref ref-type="bibr" rid="B5">Chen et al., 2014</xref>; <xref ref-type="bibr" rid="B53">Yang et al., 2018</xref>; <xref ref-type="bibr" rid="B32">Qi et al., 2019</xref>; <xref ref-type="bibr" rid="B17">Li et al., 2020</xref>; <xref ref-type="bibr" rid="B21">Luo et al., 2020</xref>). However, its effects on colorectal cancer is poorly studied. In the current study, CPT exhibited obvious cytotoxicity on both HCT116 and SW620 cells while have no remarkable effects on SW480 cells, suggesting the selectivity of CPT treatment on CRC cells.</p>
<p>Apoptosis is known as type I programmed cell death characterized by chromatin condensation, DNA fragmentation, and the formation of apoptotic bodies (<xref ref-type="bibr" rid="B50">Xie et al., 2020</xref>). Various pathways initiated by apoptosis lead to the cleavage of caspase-3, which leads to irreversible cell death (<xref ref-type="bibr" rid="B52">Xu et al., 2017</xref>; <xref ref-type="bibr" rid="B50">Xie et al., 2020</xref>). It has been reported by Xu <italic>et al</italic> that CPT induced the apoptosis in multidrug-resistant human CRC cells SW620 Ad300 (<xref ref-type="bibr" rid="B52">Xu et al., 2017</xref>). Consistent with this result, our research results show that the treatment of CPT can induce apoptosis of CRC cells HCT116 and SW620. Moreover, caspase-dependent pathway was activated and mitochondrial dysfunction occurred in response to CPT treatment in both HCT116 and SW620 cells, indicating cytotoxicity in a caspase-dependent manner.</p>
<p>Although autophagy is well recognized as a cell survival process that promotes tumor development, it can also participate in programmed cell death independent of caspase (<xref ref-type="bibr" rid="B35">Rouschop et al., 2010</xref>; <xref ref-type="bibr" rid="B6">Denton and Kumar, 2019</xref>; <xref ref-type="bibr" rid="B10">G&#xf3;mez-D&#xed;az et al., 2019</xref>). In the current study, autophagy occurrence was detected in CRC cells treated with CPT (<xref ref-type="bibr" rid="B29">Park et al., 2014</xref>; <xref ref-type="bibr" rid="B42">Wang et al., 2020</xref>). Interestingly, autophagy inhibitor selectively prevented HCT116 cells death while have negative effects on SW620 cells. It has been reported that emodin leads to apoptosis of colon cancer cells through the oxidative stress pathway in an autophagy-dependent manner (<xref ref-type="bibr" rid="B45">Wang et al., 2018</xref>). In the present study, our findings indicated that inhibition of autophagy can prevent the apoptosis of HCT116 cells induced by CPT.</p>
<p>ER stress is considered a common feature in various types of blood and solid cancers (<xref ref-type="bibr" rid="B2">Bhardwaj et al., 2019</xref>; <xref ref-type="bibr" rid="B49">Xia et al., 2021</xref>). In the current study, ER stress participation was observed in the growth and proliferation of several solid tumors, including CRC cells. Furthermore, ER stress inhibitor selectively attenuated CPT-induced cytotoxicity on HCT116, suggesting the significance of ER stress in CRC cell death. Meanwhile, ER stress inhibitor had little effects on SW620 cells. It is possible that CPT induced SW620 cell death by unknown alternative mechanisms. Literature reported that ER stress can effectively induce autophagy in cells because malignant tumor cells need to re-use their organelles to maintain growth (<xref ref-type="bibr" rid="B26">Mu&#xf1;oz-Guardiola et al., 2020</xref>). Another important finding of the current study is the involvement of ER stress in autophagy to monitor CRC growth process (<xref ref-type="fig" rid="F8">Figure 8</xref>). Above results are consistent with clinical data from CRC patients. In summary, the current study revealed the anti-cancer roles of CPT in colorectal cancer, which is mediated via autophagy signaling and ER stress. CPT is a promising therapeutic candidate for CRC treatment.</p>
<fig id="F8" position="float">
<label>FIGURE 8</label>
<caption>
<p>In the treatment of HCT116 cells by CPT, the apoptosis pathway is activated, which is associated with endoplasmic reticulum stress, and autophagy. CPT, cryptotanshinone.</p>
</caption>
<graphic xlink:href="fphar-12-653232-g008.tif"/>
</fig>
</sec>
</body>
<back>
<sec id="s5">
<title>Data Availability Statement</title>
<p>The raw data supporting the conclusion of this article will be made available by the authors, without undue reservation.</p>
</sec>
<sec id="s6">
<title>Author Contributions</title>
<p>XF and WZ wrote the manuscript, organized materials and provided concepts for the study. KL and JZ were involved in the conception of the study. XC designed the study and revised the manuscript. All authors have read and approved the final version of the manuscript.</p>
</sec>
<sec id="s7">
<title>Funding</title>
<p>This study was supported by the National Natural Science Foundation of China (81803766), the Key Research and Discovery Program of Shandong Province (2019GSF107072), the Natural Science Foundation of Shandong Province (ZR2018BH036) China Postdoctoral Science Foundation (2019M652336), and the Qingdao Postdoctoral Application Research Project and Shandong Key Research and Development Program Project (2018GSF118124).</p>
</sec>
<sec sec-type="COI-statement" id="s8">
<title>Conflicts of Interest</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
<sec id="s9">
<title>Abbreviations</title>
<p> ATF6, activating transcription factor-6; ATG, autophagy-related gene; AO, Acridine orange; BIP, immunoglobulin heavy chain binding protein in pre-B cells; BSA, bovine serum albumin; CPT, cryptotanshinone; CRC, colorectal cancer; Cis, cisplatin; ER stress, endoplasmic reticulum stress; DMSO, dimethyl sulfoxide; LDH, lactate dehydrogenase; IHC, immunohistochemistry; IRE1&#x3b1;, inositol-requiring enzyme 1&#x3b1;; 4-PBA, sodium 4-phenylbutyrate; PKR, protein kinase RNA; PERK, protein kinase RNA (PKR)-like ER kinase; UPR, unfolded protein response</p>
</sec>
<ref-list>
<title>References</title>
<ref id="B1">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Alper</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Salomatina</surname>
<given-names>O. V.</given-names>
</name>
<name>
<surname>Salakhutdinov</surname>
<given-names>N. F.</given-names>
</name>
<name>
<surname>Ulukaya</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Ari</surname>
<given-names>F.</given-names>
</name>
</person-group> (<year>2021</year>). <article-title>Soloxolone Methyl, as a 18&#x3b2;H-Glycyrrhetinic Acid Derivate, May Result in Endoplasmic Reticulum Stress to Induce Apoptosis in Breast Cancer Cells</article-title>. <source>Bioorg. Med. Chem.</source> <volume>30</volume>, <fpage>115963</fpage>. <pub-id pub-id-type="doi">10.1016/j.bmc.2020.115963</pub-id> </citation>
</ref>
<ref id="B2">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bhardwaj</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Leli</surname>
<given-names>N. M.</given-names>
</name>
<name>
<surname>Koumenis</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Amaravadi</surname>
<given-names>R. K.</given-names>
</name>
</person-group> (<year>2019</year>). <article-title>Regulation of Autophagy by Canonical and Non-canonical ER Stress Responses</article-title>. <source>Semin. Cancer Biol.</source> <volume>66</volume>, <fpage>116</fpage>-<lpage>128</lpage>. <pub-id pub-id-type="doi">10.1016/j.semcancer.2019.11.007</pub-id> </citation>
</ref>
<ref id="B3">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cai</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Shi</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>He</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>M.</given-names>
</name>
</person-group> (<year>2016</year>). <article-title>Recent Insights into the Biological Activities and Drug Delivery Systems of Tanshinones</article-title>. <source>Int. J. Nanomedicine</source> <volume>11</volume>, <fpage>121</fpage>&#x2013;<lpage>130</lpage>. <pub-id pub-id-type="doi">10.2147/ijn.S84035</pub-id> </citation>
</ref>
<ref id="B4">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chen</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>Q.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Wan</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Xin</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Cao</surname>
<given-names>Y.</given-names>
</name>
<etal/>
</person-group> (<year>2020</year>). <article-title>Cryptotanshinone Prevents Muscle Wasting in CT26-induced Cancer Cachexia through Inhibiting STAT3 Signaling Pathway</article-title>. <source>J. Ethnopharmacol</source> <volume>260</volume>, <fpage>113066</fpage>. <pub-id pub-id-type="doi">10.1016/j.jep.2020.113066</pub-id> </citation>
</ref>
<ref id="B5">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chen</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Guo</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Bao</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Lu</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>Y.</given-names>
</name>
</person-group> (<year>2014</year>). <article-title>The Anticancer Properties of Salvia Miltiorrhiza Bunge (Danshen): a Systematic Review</article-title>. <source>Med. Res. Rev.</source> <volume>34</volume> (<issue>4</issue>), <fpage>768</fpage>&#x2013;<lpage>794</lpage>. <pub-id pub-id-type="doi">10.1002/med.21304</pub-id> </citation>
</ref>
<ref id="B6">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Denton</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Kumar</surname>
<given-names>S.</given-names>
</name>
</person-group> (<year>2019</year>). <article-title>Autophagy-dependent Cell Death</article-title>. <source>Cell Death Differ</source> <volume>26</volume> (<issue>4</issue>), <fpage>605</fpage>&#x2013;<lpage>616</lpage>. <pub-id pub-id-type="doi">10.1038/s41418-018-0252-y</pub-id> </citation>
</ref>
<ref id="B7">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ding</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Cao</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Yuan</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Gong</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Zhao</surname>
<given-names>L.</given-names>
</name>
<etal/>
</person-group> (<year>2016</year>). <article-title>Development of APTES-Decorated HepG2 <italic>Cancer</italic> Stem Cell Membrane Chromatography for Screening Active Components from Salvia Miltiorrhiza</article-title>. <source>Anal. Chem.</source> <volume>88</volume> (<issue>24</issue>), <fpage>12081</fpage>&#x2013;<lpage>12089</lpage>. <pub-id pub-id-type="doi">10.1021/acs.analchem.6b02709</pub-id> </citation>
</ref>
<ref id="B8">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fang</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Huang</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Liang</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>J.</given-names>
</name>
<etal/>
</person-group> (<year>2021</year>). <article-title>Berberine-photodynamic Induced Apoptosis by Activating Endoplasmic Reticulum Stress-Autophagy Pathway Involving CHOP in Human Malignant Melanoma Cells</article-title>. <source>Biochem. Biophys. Res. Commun.</source> <volume>552</volume>, <fpage>183</fpage>&#x2013;<lpage>190</lpage>. <pub-id pub-id-type="doi">10.1016/j.bbrc.2021.02.147</pub-id> </citation>
</ref>
<ref id="B9">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ferri</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Kroemer</surname>
<given-names>G.</given-names>
</name>
</person-group> (<year>2001</year>). <article-title>Organelle-specific Initiation of Cell Death Pathways</article-title>. <source>Nat. Cel Biol</source> <volume>3</volume> (<issue>11</issue>), <fpage>E255</fpage>&#x2013;<lpage>E263</lpage>. <pub-id pub-id-type="doi">10.1038/ncb1101-e255</pub-id> </citation>
</ref>
<ref id="B10">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>G&#xf3;mez-D&#xed;az</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Ikeda</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>biology</surname>
<given-names>d.</given-names>
</name>
</person-group> (<year>2019</year>). <article-title>Roles of Ubiquitin in Autophagy and Cell Death</article-title>. <source>Semin. Cel Dev Biol.</source> <volume>93</volume>, <fpage>125</fpage>&#x2013;<lpage>135</lpage>. <pub-id pub-id-type="doi">10.1016/j.semcdb.2018.09.004</pub-id> </citation>
</ref>
<ref id="B11">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Grasso</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Pereira</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Palmeira-Dos-Santos</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Calgarotto</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Mart&#xed;nez-Lacaci</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Ferragut</surname>
<given-names>J.</given-names>
</name>
<etal/>
</person-group> (<year>2016</year>). <article-title>Autophagy Regulates Selumetinib (AZD6244) Induced-Apoptosis in Colorectal Cancer Cells</article-title>. <source>Eur. J. Med. Chem.</source> <volume>122</volume>, <fpage>611</fpage>&#x2013;<lpage>618</lpage>. <pub-id pub-id-type="doi">10.1016/j.ejmech.2016.06.043</pub-id> </citation>
</ref>
<ref id="B12">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>He</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Zhao</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Dong</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Ji</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Hao</surname>
<given-names>Y.</given-names>
</name>
<etal/>
</person-group> (<year>2020</year>). <article-title>A Biodegradable Antibacterial Alginate/carboxymethyl chitosan/Kangfuxin Sponges for Promoting Blood Coagulation and Full-Thickness Wound Healing</article-title>. <source>Int. J. Biol. Macromol</source> <volume>167</volume>, <fpage>182</fpage>&#x2013;<lpage>192</lpage>. <pub-id pub-id-type="doi">10.1016/j.ijbiomac.2020.11.168</pub-id> </citation>
</ref>
<ref id="B13">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Huang</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Su</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Fang</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Yen</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>C.</given-names>
</name>
<etal/>
</person-group> (<year>2021</year>). <article-title>Roles of ERK/Akt Signals in Mitochondria-dependent and Endoplasmic Reticulum Stress-Triggered Neuronal Cell Apoptosis Induced by 4-Methyl-2,4-Bis(4-Hydroxyphenyl)pent-1-Ene, a Major Active Metabolite of Bisphenol A</article-title>. <source>Toxicology</source> <volume>455</volume>, <fpage>152764</fpage>. <pub-id pub-id-type="doi">10.1016/j.tox.2021.152764</pub-id> </citation>
</ref>
<ref id="B14">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jhou</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Chang</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Hung</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Lin</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>W.</given-names>
</name>
<etal/>
</person-group> (<year>2020</year>). <article-title>Chlorpromazine, an Antipsychotic Agent, Induces G2/M Phase Arrest and Apoptosis via Regulation of the PI3K/AKT/mTOR-mediated Autophagy Pathways in Human Oral Cancer</article-title>. <source>Biochem. Pharmacol.</source> <volume>184</volume>, <fpage>114403</fpage>. <pub-id pub-id-type="doi">10.1016/j.bcp.2020.114403</pub-id> </citation>
</ref>
<ref id="B15">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kang</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Cheong</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>S.</given-names>
</name>
</person-group> (<year>2019</year>). <article-title>Transglutaminase 2 Promotes Autophagy by LC3 Induction through P53 Depletion in <italic>Cancer</italic> Cell</article-title>. <source>Biomol. Ther. (Seoul)</source> <volume>27</volume> (<issue>1</issue>), <fpage>34</fpage>&#x2013;<lpage>40</lpage>. <pub-id pub-id-type="doi">10.4062/biomolther.2018.140</pub-id> </citation>
</ref>
<ref id="B16">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kang</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Zeh</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Lotze</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Tang</surname>
<given-names>D.</given-names>
</name>
</person-group> (<year>2011</year>). <article-title>Differentiation. The Beclin 1 Network Regulates Autophagy and Apoptosis</article-title>. <source>Cel Death Differ</source> <volume>18</volume> (<issue>4</issue>), <fpage>571</fpage>&#x2013;<lpage>580</lpage>. <pub-id pub-id-type="doi">10.1038/cdd.2010.191</pub-id> </citation>
</ref>
<ref id="B17">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Li</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Gao</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Liang</surname>
<given-names>Q.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Zhuang</surname>
<given-names>J.</given-names>
</name>
<etal/>
</person-group> (<year>2020</year>). <article-title>Cryptotanshinone Is a Intervention for ER-Positive Breast <italic>Cancer</italic>: An Integrated Approach to the Study of Natural Product Intervention Mechanisms</article-title>. <source>Front. Pharmacol.</source> <volume>11</volume>, <fpage>592109</fpage>. <pub-id pub-id-type="doi">10.3389/fphar.2020.592109</pub-id> </citation>
</ref>
<ref id="B18">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Li</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Zheng</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Meng</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Ning</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Sun</surname>
<given-names>S.</given-names>
</name>
<etal/>
</person-group> (<year>2021</year>). <article-title>Oleandrin, a Cardiac Glycoside, Induces Immunogenic Cell Death via the PERK/elF2&#x3b1;/ATF4/CHOP Pathway in Breast Cancer</article-title>. <source>Cell Death Dis.</source> <volume>12</volume> (<issue>4</issue>), <fpage>314</fpage>. <pub-id pub-id-type="doi">10.1038/s41419-021-03605-y</pub-id> </citation>
</ref>
<ref id="B19">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Liu</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Zhan</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Xu</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>Y.</given-names>
</name>
<etal/>
</person-group> (<year>2020</year>). <article-title>Cryptotanshinone Specifically Suppresses NLRP3 Inflammasome Activation and Protects against Inflammasome-Mediated Diseases</article-title>. <source>Pharmacol. Res.</source> <volume>164</volume>, <fpage>105384</fpage>. <pub-id pub-id-type="doi">10.1016/j.phrs.2020.105384</pub-id> </citation>
</ref>
<ref id="B20">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lu</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Lawrence</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Marsters</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Acosta-Alvear</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Kimmig</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Mendez</surname>
<given-names>A.</given-names>
</name>
<etal/>
</person-group> (<year>2014</year>). <article-title>Opposing Unfolded-Protein-Response Signals Converge on Death Receptor 5 to Control Apoptosis</article-title>. <source>Science</source> <volume>345</volume> (<issue>6192</issue>), <fpage>98</fpage>&#x2013;<lpage>101</lpage>. <pub-id pub-id-type="doi">10.1126/science.1254312</pub-id> </citation>
</ref>
<ref id="B21">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Luo</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Song</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Huang</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>Q.</given-names>
</name>
<etal/>
</person-group> (<year>2020</year>). <article-title>Uncovering the Mechanisms of Cryptotanshinone as a Therapeutic Agent against Hepatocellular Carcinoma</article-title>. <source>Front. Pharmacol.</source> <volume>11</volume>, <fpage>1264</fpage>. <pub-id pub-id-type="doi">10.3389/fphar.2020.01264</pub-id> </citation>
</ref>
<ref id="B22">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Maranh&#xe3;o</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Moura</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Oliveira</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Lima</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Barros-Nepomuceno</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Paier</surname>
<given-names>C.</given-names>
</name>
<etal/>
</person-group> (<year>2020</year>). <article-title>Synthesis of PJOV56, a New Quinoxalinyl-Hydrazone Derivative Able to Induce Autophagy and Apoptosis in Colorectal Cancer Cells, and Related Compounds</article-title>. <source>Bioorg. Med. Chem. Lett.</source> <volume>30</volume> (<issue>2</issue>), <fpage>126851</fpage>. <pub-id pub-id-type="doi">10.1016/j.bmcl.2019.126851</pub-id> </citation>
</ref>
<ref id="B23">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Miller</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Fidler-Benaoudia</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Keegan</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Hipp</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Jemal</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Siegel</surname>
<given-names>R.</given-names>
</name>
</person-group> (<year>2020</year>). <article-title>
<italic>Cancer</italic> Statistics for Adolescents and Young Adults, 2020</article-title>. <source>CA Cancer J. Clin.</source> <volume>70</volume> (<issue>6</issue>), <fpage>443</fpage>&#x2013;<lpage>459</lpage>. <pub-id pub-id-type="doi">10.3322/caac.21637</pub-id> </citation>
</ref>
<ref id="B24">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mokarram</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Ahmadi</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Shojaei</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Ghavami</surname>
<given-names>S.</given-names>
</name>
</person-group> (<year>2019</year>). <article-title>Autophagy and Cancer Research in Iran</article-title>. <source>Autophagy</source> <volume>15</volume> (<issue>11</issue>), <fpage>2039</fpage>&#x2013;<lpage>2042</lpage>. <pub-id pub-id-type="doi">10.1080/15548627.2019.1606638</pub-id> </citation>
</ref>
<ref id="B25">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mowers</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Sharifi</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Macleod</surname>
<given-names>K.</given-names>
</name>
</person-group> (<year>2018</year>). <article-title>Functions of Autophagy in the Tumor Microenvironment and Cancer Metastasis</article-title>. <source>FEBS J.</source> <volume>285</volume> (<issue>10</issue>), <fpage>1751</fpage>&#x2013;<lpage>1766</lpage>. <pub-id pub-id-type="doi">10.1111/febs.14388</pub-id> </citation>
</ref>
<ref id="B26">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mu&#xf1;oz-Guardiola</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Casas</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Meg&#xed;as-Roda</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Sol&#xe9;</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Perez-Montoyo</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Yeste-Velasco</surname>
<given-names>M.</given-names>
</name>
<etal/>
</person-group> (<year>2020</year>). <article-title>The Anti-cancer Drug ABTL0812 Induces ER Stress-Mediated Cytotoxic Autophagy by Increasing Dihydroceramide Levels in Cancer Cells</article-title>. <source>Autophagy</source>, <fpage>1</fpage>&#x2013;<lpage>18</lpage>. <pub-id pub-id-type="doi">10.1080/15548627.2020.1761651</pub-id> </citation>
</ref>
<ref id="B27">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nagappan</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Yun</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Lu</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Chang</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Jeong</surname>
<given-names>J.</given-names>
</name>
<etal/>
</person-group> (<year>2017</year>). <article-title>Tetraarsenic Hexoxide Induces G2/M Arrest, Apoptosis, and Autophagy via PI3K/Akt Suppression and P38 MAPK Activation in SW620 Human Colon Cancer Cells</article-title>. <source>PLoS One</source> <volume>12</volume> (<issue>3</issue>), <fpage>e0174591</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pone.0174591</pub-id> </citation>
</ref>
<ref id="B28">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Noguchi</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Hirata</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Tanaka</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Suizu</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Nakajima</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Chiorini</surname>
<given-names>J.</given-names>
</name>
<etal/>
</person-group> (<year>2020</year>). <article-title>Autophagy as a Modulator of Cell Death Machinery</article-title>. <source>Cel Death Dis.</source> <volume>11</volume> (<issue>7</issue>), <fpage>517</fpage>. <pub-id pub-id-type="doi">10.1038/s41419-020-2724-5</pub-id> </citation>
</ref>
<ref id="B29">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Park</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Nam</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Hong</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>J.</given-names>
</name>
<etal/>
</person-group> (<year>2014</year>). <article-title>Cryptotanshinone Induces G1 Cell Cycle Arrest and Autophagic Cell Death by Activating the AMP-Activated Protein Kinase Signal Pathway in HepG2 Hepatoma</article-title>. <source>Apoptosis</source> <volume>19</volume> (<issue>4</issue>), <fpage>615</fpage>&#x2013;<lpage>628</lpage>. <pub-id pub-id-type="doi">10.1007/s10495-013-0929-0</pub-id> </citation>
</ref>
<ref id="B30">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pedro</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Wei</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Sica</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Maiuri</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Zou</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Kroemer</surname>
<given-names>G.</given-names>
</name>
<etal/>
</person-group> (<year>2015</year>). <article-title>BAX and BAK1 Are Dispensable for ABT-737-Induced Dissociation of the BCL2-BECN1 Complex and Autophagy</article-title>. <source>Autophagy</source> <volume>11</volume> (<issue>3</issue>), <fpage>452</fpage>&#x2013;<lpage>459</lpage>. <pub-id pub-id-type="doi">10.1080/15548627.2015.1017191</pub-id> </citation>
</ref>
<ref id="B31">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Prasad</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Greber</surname>
<given-names>U.</given-names>
</name>
</person-group> (<year>2021</year>). <article-title>The Endoplasmic Reticulum Unfolded Protein Response - Homeostasis, Cell Death and Evolution in Virus Infections</article-title>. <source>FEMS Microbiol. Rev.</source> <pub-id pub-id-type="doi">10.1093/femsre/fuab016</pub-id> </citation>
</ref>
<ref id="B32">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Qi</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Jafari</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Sun</surname>
<given-names>Q.</given-names>
</name>
<etal/>
</person-group> (<year>2019</year>). <article-title>Cryptotanshinone Suppresses Non-small Cell Lung <italic>Cancer</italic> via microRNA-146a-5p/EGFR <italic>Axis</italic>
</article-title>. <source>Int. J. Biol. Sci.</source> <volume>15</volume> (<issue>5</issue>), <fpage>1072</fpage>&#x2013;<lpage>1079</lpage>. <pub-id pub-id-type="doi">10.7150/ijbs.31277</pub-id> </citation>
</ref>
<ref id="B33">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rah</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>ur Rasool</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Nayak</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Yousuf</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Mukherjee</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Kumar</surname>
<given-names>L.</given-names>
</name>
<etal/>
</person-group> (<year>2015</year>). <article-title>PAWR-mediated Suppression of BCL2 Promotes Switching of 3-azido Withaferin A (3-Awa)-Induced Autophagy to Apoptosis in Prostate Cancer Cells</article-title>. <source>Autophagy</source> <volume>11</volume> (<issue>2</issue>), <fpage>314</fpage>&#x2013;<lpage>331</lpage>. <pub-id pub-id-type="doi">10.1080/15548627.2015.1017182</pub-id> </citation>
</ref>
<ref id="B34">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Roessler</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Jia</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Budhu</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Forgues</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Ye</surname>
<given-names>Q.</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>J.</given-names>
</name>
<etal/>
</person-group> (<year>2010</year>). <article-title>A Unique Metastasis Gene Signature Enables Prediction of Tumor Relapse in Early-Stage Hepatocellular Carcinoma Patients</article-title>. <source>Cancer Res.</source> <volume>70</volume> (<issue>24</issue>), <fpage>10202</fpage>&#x2013;<lpage>10212</lpage>. <pub-id pub-id-type="doi">10.1158/0008-5472.Can-10-2607</pub-id> </citation>
</ref>
<ref id="B35">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rouschop</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>van den Beucken</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Dubois</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Niessen</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Bussink</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Savelkouls</surname>
<given-names>K.</given-names>
</name>
<etal/>
</person-group> (<year>2010</year>). <article-title>The Unfolded Protein Response Protects Human Tumor Cells during Hypoxia through Regulation of the Autophagy Genes MAP1LC3B and ATG5</article-title>. <source>J. Clin. Invest.</source> <volume>120</volume> (<issue>1</issue>), <fpage>127</fpage>&#x2013;<lpage>141</lpage>. <pub-id pub-id-type="doi">10.1172/jci40027</pub-id> </citation>
</ref>
<ref id="B36">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Schleicher</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Moretti</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Varki</surname>
<given-names>V.</given-names>
</name>
</person-group> (<year>2010</year>). <article-title>Lu BJDrur, Antimicrobial Ci, Chemotherapy a. Progress in the Unraveling of the Endoplasmic Reticulum Stress/autophagy Pathway and Cancer: Implications for Future Therapeutic Approaches</article-title>. <source>Drug Resist. Updat</source> <volume>13</volume> (<issue>3</issue>), <fpage>79</fpage>&#x2013;<lpage>86</lpage>. <pub-id pub-id-type="doi">10.1016/j.drup.2010.04.002</pub-id> </citation>
</ref>
<ref id="B37">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Siegel</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Miller</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Goding Sauer</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Fedewa</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Butterly</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Anderson</surname>
<given-names>J.</given-names>
</name>
<etal/>
</person-group> (<year>2020</year>). <article-title>Colorectal Cancer Statistics 2020</article-title>. <source>CA Cancer J. Clin.</source> <volume>70</volume> (<issue>3</issue>), <fpage>145</fpage>&#x2013;<lpage>164</lpage>. <pub-id pub-id-type="doi">10.3322/caac.21601</pub-id> </citation>
</ref>
<ref id="B38">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Siegel</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Miller</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Jemal</surname>
<given-names>A. J.</given-names>
</name>
</person-group> (<year>2020a</year>). <article-title>
<italic>Cancer</italic> Statistics, 2020</article-title>. <source>CA Cancer J. Clin.</source> <volume>70</volume> (<issue>1</issue>), <fpage>7</fpage>&#x2013;<lpage>30</lpage>. <pub-id pub-id-type="doi">10.3322/caac.21590</pub-id> </citation>
</ref>
<ref id="B39">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sun</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Zhao</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Sun</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>X.</given-names>
</name>
</person-group> (<year>2020</year>). <article-title>A Pharmacological Review of Dicoumarol: An Old Natural Anticoagulant Agent</article-title>. <source>Pharmacol. Res.</source> <volume>160</volume>, <fpage>105193</fpage>. <pub-id pub-id-type="doi">10.1016/j.phrs.2020.105193</pub-id> </citation>
</ref>
<ref id="B40">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>van Anken</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Bakunts</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Hu</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Janssens</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Sitia</surname>
<given-names>R.</given-names>
</name>
</person-group> (<year>2021</year>). <article-title>Molecular Evaluation of Endoplasmic Reticulum Homeostasis Meets Humoral Immunity</article-title>. <source>Trends Cel Biol</source>. <fpage>S0962-8924(21)00029-5</fpage>. <pub-id pub-id-type="doi">10.1016/j.tcb.2021.02.004</pub-id> </citation>
</ref>
<ref id="B41">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Walter</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Ron</surname>
<given-names>D.</given-names>
</name>
</person-group> (<year>2011</year>). <article-title>The Unfolded Protein Response: from Stress Pathway to Homeostatic Regulation</article-title>. <source>Science</source> <volume>334</volume> (<issue>6059</issue>), <fpage>1081</fpage>&#x2013;<lpage>1086</lpage>. <pub-id pub-id-type="doi">10.1126/science.1209038</pub-id> </citation>
</ref>
<ref id="B42">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Guan</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Yu</surname>
<given-names>W.</given-names>
</name>
<etal/>
</person-group> (<year>2020</year>). <article-title>LYW-6, a Novel Cryptotanshinone Derived STAT3 Targeting Inhibitor, Suppresses Colorectal Cancer Growth and Metastasis</article-title>. <source>Pharmacol. Res.</source> <volume>153</volume>, <fpage>104661</fpage>. <pub-id pub-id-type="doi">10.1016/j.phrs.2020.104661</pub-id> </citation>
</ref>
<ref id="B43">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Wei</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Zhu</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>Z.</given-names>
</name>
<etal/>
</person-group> (<year>2020a</year>). <article-title>Cryptotanshinone Alleviates Chemotherapy-Induced Colitis in Mice with Colon Cancer via Regulating Fecal-Bacteria-Related Lipid Metabolism</article-title>. <source>Pharmacol. Res.</source>, <fpage>105232</fpage>. <pub-id pub-id-type="doi">10.1016/j.phrs.2020.105232</pub-id> </citation>
</ref>
<ref id="B44">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Kaufman</surname>
<given-names>R.</given-names>
</name>
</person-group> (<year>2016</year>). <article-title>Protein Misfolding in the Endoplasmic Reticulum as a Conduit to Human Disease</article-title>. <source>Nature</source> <volume>529</volume> (<issue>7586</issue>), <fpage>326</fpage>&#x2013;<lpage>335</lpage>. <pub-id pub-id-type="doi">10.1038/nature17041</pub-id> </citation>
</ref>
<ref id="B45">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Luo</surname>
<given-names>Q.</given-names>
</name>
<name>
<surname>He</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Wei</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Shao</surname>
<given-names>J.</given-names>
</name>
<etal/>
</person-group> (<year>2018</year>). <article-title>Emodin Induces Apoptosis of Colon <italic>Cancer</italic> Cells via Induction of Autophagy in a ROS-dependent Manner</article-title>. <source>Oncol. Res.</source> <volume>26</volume> (<issue>6</issue>), <fpage>889</fpage>&#x2013;<lpage>899</lpage>. <pub-id pub-id-type="doi">10.3727/096504017x15009419625178</pub-id> </citation>
</ref>
<ref id="B46">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Zhou</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Ye</surname>
<given-names>J.</given-names>
</name>
</person-group> (<year>2021</year>). <article-title>Role of the mTOR-Autophagy-ER Stress Pathway in High Fructose-Induced Metabolic-Associated Fatty Liver Disease</article-title>. <source>Acta Pharmacol. Sin</source>. <pub-id pub-id-type="doi">10.1038/s41401-021-00629-0</pub-id> </citation>
</ref>
<ref id="B47">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wu</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Yu</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Yuan</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Hurst</surname>
<given-names>D.</given-names>
</name>
<etal/>
</person-group> (<year>2020</year>). <article-title>HITTERSLong Noncoding RNA Protects Oral Squamous Cell Carcinoma Cells from Endoplasmic Reticulum Stress-Induced Apoptosis via Promoting MRE11-RAD50-NBS1 Complex Formation</article-title>. <source>Adv. Sci. (Weinh)</source> <volume>7</volume> (<issue>22</issue>), <fpage>2002747</fpage>. <pub-id pub-id-type="doi">10.1002/advs.202002747</pub-id> </citation>
</ref>
<ref id="B48">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Xia</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Ji</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Xu</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Lin</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Xia</surname>
<given-names>Y.</given-names>
</name>
<etal/>
</person-group> (<year>2017</year>). <article-title>Knockout of MARCH2 Inhibits the Growth of HCT116 Colon Cancer Cells by Inducing Endoplasmic Reticulum Stress</article-title>. <source>Cel Death Dis.</source> <volume>8</volume> (<issue>7</issue>), <fpage>e2957</fpage>. <pub-id pub-id-type="doi">10.1038/cddis.2017.347</pub-id> </citation>
</ref>
<ref id="B49">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Xia</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Yu</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Shen</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Qiu</surname>
<given-names>C.</given-names>
</name>
<etal/>
</person-group> (<year>2021</year>). <article-title>Compensatory Combination of mTOR and TrxR Inhibitors to Cause Oxidative Stress and Regression of Tumors</article-title>. <source>Theranostics</source> <volume>11</volume> (<issue>9</issue>), <fpage>4335</fpage>&#x2013;<lpage>4350</lpage>. <pub-id pub-id-type="doi">10.7150/thno.52077</pub-id> </citation>
</ref>
<ref id="B50">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Xie</surname>
<given-names>Q.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>X.</given-names>
</name>
</person-group> (<year>2020</year>). <article-title>The Interaction Mechanism between Autophagy and Apoptosis in Colon Cancer</article-title>. <source>Transl Oncol.</source> <volume>13</volume> (<issue>12</issue>), <fpage>100871</fpage>. <pub-id pub-id-type="doi">10.1016/j.tranon.2020.100871</pub-id> </citation>
</ref>
<ref id="B51">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Xu</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Lin</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Da</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Wen</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Ding</surname>
<given-names>J.</given-names>
</name>
<etal/>
</person-group> (<year>2012</year>). <article-title>Cryptotanshinone Suppresses Androgen Receptor-Mediated Growth in Androgen Dependent and Castration Resistant Prostate Cancer Cells</article-title>. <source>Cancer Lett.</source> <volume>316</volume> (<issue>1</issue>), <fpage>11</fpage>&#x2013;<lpage>22</lpage>. <pub-id pub-id-type="doi">10.1016/j.canlet.2011.10.006</pub-id> </citation>
</ref>
<ref id="B52">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Xu</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Jiang</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Zhu</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Jiang</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>L.</given-names>
</name>
<etal/>
</person-group> (<year>2017</year>). <article-title>Cryptotanshinone Induces ROS-dependent Autophagy in Multidrug-Resistant Colon Cancer Cells</article-title>. <source>Chem. Biol. Interact</source> <volume>273</volume>, <fpage>48</fpage>&#x2013;<lpage>55</lpage>. <pub-id pub-id-type="doi">10.1016/j.cbi.2017.06.003</pub-id> </citation>
</ref>
<ref id="B53">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yang</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Cao</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Qi</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Cheng</surname>
<given-names>X.</given-names>
</name>
<etal/>
</person-group> (<year>2018</year>). <article-title>Cryptotanshinone Suppresses Cell Proliferation and Glucose Metabolism via STAT3/SIRT3 Signaling Pathway in Ovarian Cancer Cells</article-title>. <source>Cancer Med.</source> <volume>7</volume> (<issue>9</issue>), <fpage>4610</fpage>&#x2013;<lpage>4618</lpage>. <pub-id pub-id-type="doi">10.1002/cam4.1691</pub-id> </citation>
</ref>
<ref id="B54">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhao</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Gao</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Cui</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Jiang</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Cui</surname>
<given-names>J.</given-names>
</name>
<etal/>
</person-group> (<year>2021</year>). <article-title>Inhibition of PTEN Ameliorates Secondary Hippocampal Injury and Cognitive Deficits after Intracerebral Hemorrhage: Involvement of AKT/FoxO3a/ATG-Mediated Autophagy</article-title>. <source>Oxid Med. Cel Longev</source> <volume>2021</volume>, <fpage>5472605</fpage>. <pub-id pub-id-type="doi">10.1155/2021/5472605</pub-id> </citation>
</ref>
<ref id="B55">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhao</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Zhou</surname>
<given-names>Q.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Han</surname>
<given-names>Y.</given-names>
</name>
<etal/>
</person-group> (<year>2020</year>). <article-title>Dihydrotanshinone I Attenuates Plaque Vulnerability in Apolipoprotein E-Deficient Mice: Role of Receptor-Interacting Protein 3</article-title>. <source>Antioxid. Redox Signal.</source> <volume>34</volume> (<issue>5</issue>), <fpage>351</fpage>&#x2013;<lpage>363</lpage>. <pub-id pub-id-type="doi">10.1089/ars.2019.7796</pub-id> </citation>
</ref>
<ref id="B56">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhao</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Zeng</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Meng</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Bi</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Xu</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>X.</given-names>
</name>
<etal/>
</person-group> (<year>2019</year>). <article-title>Structural Characterization and In Vitro-In Vivo Evaluation of Effect of a Polysaccharide from Sanguisorba Officinalis on Acute Kidney Injury</article-title>. <source>Food Funct.</source> <volume>10</volume> (<issue>11</issue>), <fpage>7142</fpage>&#x2013;<lpage>7151</lpage>. <pub-id pub-id-type="doi">10.1039/c9fo01891c</pub-id> </citation>
</ref>
<ref id="B57">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zheng</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Feng</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Han</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Zhao</surname>
<given-names>W.</given-names>
</name>
</person-group> (<year>2020</year>). <article-title>Targeting Autophagy by Natural Product Ursolic Acid for Prevention and Treatment of Osteoporosis</article-title>. <source>Toxicol. Appl. Pharmacol.</source> <volume>409</volume>, <fpage>115271</fpage>. <pub-id pub-id-type="doi">10.1016/j.taap.2020.115271</pub-id> </citation>
</ref>
</ref-list>
</back>
</article>